NCT00296023View on ClinicalTrials.gov

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2008

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic Syndromes
Interventions
BIOLOGICAL

anti-thymocyte globulin

BIOLOGICAL

filgrastim

BIOLOGICAL

therapeutic allogeneic lymphocytes

DRUG

busulfan

DRUG

fludarabine phosphate

DRUG

methotrexate

DRUG

tacrolimus

PROCEDURE

nonmyeloablative allogeneic hematopoietic stem cell transplantation

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (2)

94704

Alta Bates Comprehensive Cancer Center, Berkeley

94143-0324

UCSF Comprehensive Cancer Center, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00296023 - Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer | Biotech Hunter | Biotech Hunter